Sign Out
If patients are pregnant or breast-feeding, think they may be pregnant or are planning to have a baby, they should be advised before taking this medicine.
This medicine should not be given when breast-feeding, as small amounts of ZYLANZA can pass into breast milk.
The following symptoms may occur in newborn babies of mothers who have used ZYLANZA in the last trimester: shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding. If the baby develops any of these symptoms, patients may need to contact their physician.
